Cloud-based technology has enabled one healthcare provider’s swift transition to a new cancer treatment guideline.The private Sydney Adventist Hospital (the San) in Sydney’s north is an early adopter of the NSW Cancer Institute’s guideline…
Continue Reading
What You Should Know:
– AccessHope, a company revolutionizing how cancer patients receive cutting-edge treatment plans secures $33M in a Series B funding round led by City of Hope, a prominent cancer research and treatment…
Continue Reading
What You Should Know:
– Just weeks after acquiring MIM Software, a leader in medical imaging analysis and AI solutions, GE HealthCare strengthens its commitment to improving cancer care through a deeper collaboration with Elekta,…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
What You Should Know:
– Scopio Labs, a leader in digital cell morphology, has achieved a major breakthrough with FDA De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
– The FDA clearance marks…
Continue Reading
Accurate prediction of recurrence and progression in non-muscle invasive bladder cancer (NMIBC) is essential to inform management and eligibility for clinical trials. Despite substantial interest in developing artificial intelligence (AI) applications in NMIBC, their…
Continue Reading
Included Health, a navigation and virtual care company, is growing its services to include a new specialty care clinic, which will provide virtual support for costly conditions like cancer, the company announced Wednesday.
San Francisco-based…
Continue Reading
By Shania Kennedy
April 18, 2024 – Artificial intelligence (AI)-driven tools can improve the skin cancer diagnostic accuracy of clinicians, nurse practitioners and medical students, according to a study published last week in npj Digital Medicine.
The…
The University of Pittsburgh Medical Center (UPMC) has developed a groundbreaking predictive model for metastatic uveal melanoma patients’ response to adoptive therapy, offering hope in treating this resistant cancer. Led by Dr. Udai Kammula,…
Continue Reading
What You Should Know:
– COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
– The strategic partnership aims to leverage RWD and artificial intelligence (AI) to…
Continue Reading
